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INTRODUCTION
Cancer, defined as uncontrolled proliferation and spread of abnormal cells, is one of the most important health problems of our time. It is also a public health problem because of its frequent appearance and high mortality. The rapid rise of cancer cases in the world and in our country and the fact that they are among the first causes of deaths suggests that further studies on the development of new drugs and treatment methods should be conducted in this regard. According to the latest data of association in Turkey fight cancer, is the second highest incidence of cancer among men with prostate cancer was 37.6%.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most used up medicinal drugs generally used as anti-inflammatory, antipyretic and analgesic drugs and their side-effects were worked involving gastrointestinal and cardiovascular risks [1] . (+)-(S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid (Naproxen) is a non-steroidal anti-inflammatory drug which contains carboxylic acid funcionality with antipyretic and analgesic properties. It is thought to study by reducing the action of cyclooxygenase (COX) included in the production of prostaglandins that are manufactured in answer to certain diseases or injury and cause pain, inflammation and swelling [2] . As well as other NSAIDs, naproxen was reported to be efficient in the prevention of many cancers [3] [4] [5] . Hydrazide-hydrazones [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] and 1,2,4-triazole rings [22] [23] [24] [25] [26] have diverse biological activities.
In this study, 1,2,4-triazole containing hydrazide-hydrazones derived from naproxen have been synthesized. The purity of the synthesized compounds have been proven by thin layer chromatography (TLC) and high pressure liquid chromatography (HPLC), elementel analysis and melting point assay. Their structures have been characterized by 1 H-NMR, 13 C-NMR, HR-MS and FT-IR spectroscopic methods. The anticancer activity of the synthesized compounds were studied against PC-3, DU-143 and LNCaP prostate cancer cell lines. the range of 0.9-1.3 ppm and 1.2-1.9 ppm, respectively. The -OH protons were observed at the range of 4.0-5.6 ppm.
The HR-MS spectra of six novel naproxen derivatives were studied in this study. The ionization format of 7e and 7j was electron impact (EI); the ionization format of compounds 5, 6, 7b and 7c was electron spray impact (ESI). Compounds 7e and 7j gave the peak at their molecular weight. Other compounds gave the peak at [M+1] because of catching a hydrogen atom from medium. HR-MS spectrum of selected compound 7e displayed molecular ion peak at m/z 379. The major fragmentation pathway appeared by the cleavage of -CH2-CONHN=CH-Ar bonds of amide moiety (Figure 2 ). 
Biological activity
The anticancer activity of naproxen, the synthesis starting compound, has been reported. On the light of foregoing, we aimed to investigate the anticancer activity of (S)-naproxen hydrazide-hydrazones (7a-m). The anticancer activity of all compounds was evaluated in Faculty of Pharmacy, Erciyes University. The sensitivity of the proatate cancer cell lines towards the compounds was evaluated from MTS method [29] . The anticancer activity of the compounds were evaluated against three cancer cell lines. The cell lines used were PC-3 and DU-143 (androgen-independent human prostate cancer cell lines) and LNCaP (androgensensitive human prostate adenocarcinoma) prostate cancer cell lines. Cisplatin was used as the positive sensitivity reference standard for cell lines. Compounds 7a-m were found with IC50 values of 87.2-400 µM according to MTS assay. The results of anticancer activity of synthesized compounds 7a-m are given Table 1 . A computational study for prediction of ADME properties of the molecules was applied by determination of lipophilicity, topological polar surface area (TPSA), absorption (% ABS) and simple molecular descriptors used by Lipinski in formulating his "rule of five". Calculations were performed using Molinspiration on-line property calculation toolkit (http://www.molinspiration.com) [30] ( Table 2) . Percentage of absorption (% ABS) was estimated using the equation: % ABS = 109 -(0.345 × TPSA) [31] . Table 2 . Predicted ADME, Lipinski parameters and molecular properties of the synthesized compounds 7a-m. 
CONCLUSION
Naproxen containing 1,2,4-triazole derivatives 5, 6 and 7a-m were synthesized and evaluated for their anticancer activity in this study. All of the compounds tested (compounds 7a-m) were found to be no or weak activity against PC-3, DU-145 and LNCaP cancer cell lines. Cisplatin was used as the positive sensitivity reference standard for cell lines.
MATERIALS AND METHODS
(S)-Naproxen was liberally ensured Abdi İbrahim. All aldehydes were purchased from Fluka and Aldrich. All other chemicals were purchased from Merck. Melting points were taken on Schmelzpunktbestimmer 9300 SMP II apparatus and are uncorrected. Synthesis of these compounds were carried out in Memmert WNB14 instrument and Heidolph MR Plug radley. Merck silica gel 60 F254 plates were used for analytical TLC. The purity of the compounds was controlled on TLC plates precoated with silica gel G in a solvent system comprising of petroleum ether: ethyl acetate (40:60, v/v) mixture as an eluent. The spots were located under UV light (254 nm) (t: 21 o C). HPLC data were performed on Agilent Technologies 1100 series. The separation was performed at ambient temperature using a reverse phase ZORBAX C8 column. All experiments were performed in gradient mode. Acetonitrile:bidistillee water system was used as gradient system: 50:50 from 0 to 5 min; 75:25 to 50:50 from 5 to 7 min; 100:0 to 75:25 from 7 to 15 min; the flow rate was 1.0 mL/min with monitoring at 254 nm (M1). Chromatographic data were collected and processed using Agilent Chemstation Plus software. Elemental analyses were performed on VarioMICRO V1.5.7. instrument. FT-IR spectra were run on Schimadzu FTIR-8400S spectrophotometer. 1 H-NMR and 13 C-NMR spectra were obtained on a BRUKER AVANCE-DPX 300 instrument (Elementel analysis, 1 H-NMR and 13 C-NMR spectrum exist in İnönü University Scientific and Technological Research Center). MALDI-TOF HR-MS spectra using the EI and ESI ionization techniques were performed using a Jeol JMS-700 instrument. Optical rotation angle measurement for Naproxen was performed on a Rudolph Autopol V Plus brand / model polarimeter.
Chemistry

Preparation of (S)-methyl 2-(6-methoxy-2-naphthyl)propanoate (1, CAS Number: 26159-35-3)
In a few drops of concentrated sulfuric acid, Naproxen (0.05 mol) and methanol (50 mL) were refluxed for 8 h. The contents of the flask were cooled and neutralized by using NaHCO3 (5%). The resulting precipitate was filtered, dried, and recrystallized from ethanol. Yield 75%; M.p. 100-101 °C (lit 88 °C) [32, 33] .
Preparation of (S)-2-(6-methoxy-2-naphthyl)propanoic acid hydrazide (2, CAS Number: 57475-91-9)
To a ethanolic solution of compound (1) (20 mL, 0.01 mol) was added hydrazine-hydrate (80%, 20 mL) and refluxed for 4 h. The reaction mixture was then cooled, diluted with water and allowed to stand overnight. The precipitated solid was washed with water, dried, and recrystallized from ethanol. Yield 70%; M.p. 137 °C (lit 94) [33] .
Preparation of (S)-N-(4-fluorophenyl)-2-[2-(6-methoxynaphtalen-2-yl)propanoyl]hydrazinecarbothio amide (3, CAS Number: 1003001-33-9)
A solution of compound (2) (0.01 mol) and equimolar amount of 4-fluorophenyl isothiocyanate in nbutanol (20 mL) was heated on radley for 4 h. After the mixture was cooled at room temperature and nbutanol was evaporated. The product was dried and recrystallized with ethanol. Yield 75%; M.p. 158-160 °C (lit 162°C) [33] .
Preparation of (S)-5-[1-(6-methoxynaphtalen-2-yl)ethyl]-4-fluorophenyl-4H-1,2,4-triazole-3-thione (4, CAS Number: 1003001-45-3)
A solution of compound (3) (0.01 mol) in 4N sodium hydroxide solution (30 mL) was heated under radley for 16 h. After cooling to room temperature, the solution was adjusted to pH 6 by glacial acetic acid. The crude product was precipitated, filtered and washed with distilled water. The product was get by recrystallization from ethanol. Yield 60%; 145-146 °C (lit 144 °C) [33] .
Synthesis of (S)-ethyl{[4-(4-fluorophenyl)-5-[(1-(6-methoxynaphtalen-2-yl)ethyl)]-4H-1,2,4-triazole-3-yl]sulphanyl}acetate (5)
Compound (4) (0.001 mol) was dissolved in 30 mL of acetone (30 mL) and potassium carbonate (0.002 mol) was added to solution. Then, ethyl bromoacetate (0.0011 mol) were added to the solution to divide four times at 15 minutes intervals. The content of the flask was stirred at room temperature for 20 h. The mixture was filtered of inorganic compounds. Then, aceton was evaporated and the precipitated compound was filtered, dried and recrystallized from methanol. 
Synthesis of (S)-2-({5-[1-(6-methoxynaphtalen-1-yl)ethyl]-4-fluorophenyl-4H-1,2,4-triazole-3-yl} sulphanyl)acetohydrazide (6)
To a mixture of compound (5) (0.001 mol) and hydrazine hydrate (0.003 mol, %80), absolute ethanol (50 mL) was added and it was refluxed for 6 h on a water bath. The mixture was concentrated, cooled, and poured into cold water. It was kept for 24h at fridge and the solid mass separated out was filtered, dried, and recrystallized from ethanol.
Yield 
General Procedure for the synthesis of (S)-2-{[5-[1-(6-methoxynaphtalen-2-yl)ethyl]-4-(4-fluorophenyl)-4H-1,2,4-triazole-3-yl]sulphanyl}-N'-[(substituted phenyl) methylidene]acetohydrazides (7a-m)
Compound (6) (0.001 mol) was dissolved in absolute ethanol. A few drop glacial acetic acid were added to solution. Equimolar amount of the appropriate aromatic aldehyde were added and refluxed for 8 h. The flask content was allowed to cool, and the filtered and dried precipitate were recrystallized from ethanol. 33 (2s, 2H, SCH2 2-{[5-[1-(6-Methoxynaphtalen-2-yl)ethyl]-4-(4-fluorophenyl)-4H-1,2,4-triazole-3-yl]sulphanyl}-N'-[(2,6-dichlorophenyl 
